drugset / Trial / NCT06253845
Study of CG0070 After Transurethral Resection in Patients With IR NMIBC
NaSingle-groupOpen-labelTreatment
Summary
Investigators will evaluate the safety of CG0070 for the treatment of patients with Intermediate-Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC).
Timeline
- Start
- 2024-03-01
- Primary completion
- 2027-09
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cretostimogene Grenadenorepvec | Unknown | 1e+12 unknown | Other |